Cicor Technologies · SIX:CICN

Cicor Technologies — Investora 2020

28 slides from Cicor Technologies's conference presentation, Sep 24, 2020

  1. Slide 1: Investora 2020

    Investora 2020 Cicor Technologies Ltd. September 24, 2020 Cicor Technologies Ltd. Bloom Diagnostics AG Alexander Hagemann Dr. med. Angelica Kohlmann CEO Co-founder & Executive Chairman Patric Schoch CFO

  2. Slide 2: Disclaimer

    Disclaimer September 24, 2020 The information in this presentation does not constitute an offer or invitation and may not be construed as a recommendation by us to purchase, hold or sell shares of Cicor Technologies Ltd. This information or any copy thereof may not be sent or taken to or distributed

  3. Slide 3: The Cicor Group

    The Cicor Group Your technology partner  Swiss leader in design and manufacturing of advanced electronics  Pioneering microelectronics since 1966 – listed at SIX Swiss Exchange in 1998  Focus on high value applications: Medical, industrial, aerospace & defence  2019 net sales of CHF 254 million,

  4. Slide 4: Leading technologies for advanced electronics

    Leading technologies for advanced electronics An unparalleled offering of products and services AMS Division ES Division Advanced Microelectronics and Substrates Share of Sales Electronic Solutions Share of Sales The strongest platform in the industry for Realization of advanced electronic devices a

  5. Slide 5: Global footprint

    Global footprint High tech and competitiveness – close to the customer 5

  6. Slide 6: Cicor in H1/2020

    Cicor in H1/2020 Financials reflect resilience in the challenging COVID-19 environment  Net sales of CHF 109 million (minus 17.3% to PY, in local currencies minus 13.6%)  EBITDA margin of 8.5% (PY: 9.0%)  New orders of CHF 92.6 million (minus 17.2%) – starting to recover in Q3  Medical sales alm

  7. Slide 7: Record high new business pipeline

    Record high new business pipeline  Highest ever volume of quoted new projects Annual sales opportunity from quoted new business  Cicor USP well recognized by OEM for high-end 300% electronics 250%  Trade tensions and COVID-19 pandemic are driving Nearshoring and China+1 strategies in the electron

  8. Slide 8: Strong position in an attractive market

    Alexander Hagemann Strong position in an attractive market

  9. Slide 9: Strong position in an attractive market

    Strong position in an attractive market Introduction Operating in a Focus on attractive Winning market Leading position in growth market applications share the D-A-CH region 9

  10. Slide 10: Operating in a growth market

    Operating in a growth market Electronic Manufacturing Services (EMS) industry revenues with 14% CAGR since 1990 «The electronics super- cycle is driven by demand for the connection of everything.» «The resilience of the industry, diverse customer base, … and the electronics super- cycle are driving

  11. Slide 11: Focus on attractive applications

    Focus on attractive applications A.I.M. - Segments with highest margins and customer loyalty due to quality requirements and innovation Aerospace & Defence Industrial Medical 11

  12. Slide 12: Winning market share

    Winning market share Increasing market share in A.I.M. target sectors 150.0% 148.1% Cicor’s unique selling propositions (USP): 140.1%  Design excellence 140.0% More than 150 engineers for HW/SW development, product- and process engineering, project management 130.0%  Technology leadership 124.0% 1

  13. Slide 13: Leading position in the D-A-CH region

    Leading position in the D-A-CH region As top 3 player in the relevant market, Cicor has a strong foundation for further growth Regional leadership  Customers are «hidden champions» and innovation leaders in D-A-CH  Close communication between partners  Aiming for No. 2 in D-A-CH in A.I.M. markets

  14. Slide 14: Financial Results H1/2020

    Patric Schoch Financial Results H1/2020

  15. Slide 15: Financial achievements H1/2020

    Financial achievements H1/2020 All figures in CHF million at actual FX rates Orders received Net sales EBIT EBITDA Net profit -17.3% -22.3% -17.2% -41.9% -56.6% 9.0% 8.5% 5.3% (ROS) 3.7% 2.9% 1.5% 2019 2020 2019 2020 2019 2020 2019 2020 2019 2020  Sales decline of -13.6% in local currencies 15

  16. Slide 16: Successful financial management to secure results in H1/2020

    Successful financial management to secure results in H1/2020 Four important topics under special focus during the first semester 1 Strong cost discipline: Actively managing and monitoring company spend in H1 helped to secure the company results. 2 Being profitable: Net profit of CHF 1.7 million achi

  17. Slide 17: Case study – partnering with innovation leaders

    Alexander Hagemann Case study – partnering with innovation leaders

  18. Slide 18: Value proposition

    Value proposition Cicor Group  Engineering and consulting  Life cycle services  Swiss Quality  Industry 4.0 assembly  One-stop-shop  Microelectronics  Global footprint  High precision substrates  Micro molding  Electronic printing 18

  19. Slide 19: Bloom Diagnostics AG & Cicor Technologies Ltd.

    Dr. med. Angelica Kohlmann Bloom Diagnostics AG & Cicor Technologies Ltd.

  20. Slide 20: Bloom Diagnostics AG – Cicor Technologies Ltd.

    Cicor Site Bronschhofen, Switzerland Bloom Diagnostics AG – Cicor Technologies Ltd.

  21. Slide 21: Bloom Diagnostics AG – Cicor Technologies Ltd.

    Bloom Diagnostics AG – Cicor Technologies Ltd. 2018 Bloom, a health tech startup, engages with Cicor as CDMO: • 1st stage: Development of a “mini-lab” (or reader) to quantify results of rapid blood-test (or other bodily fluids), including electronic boards, hardware and firmware, compatible with Blu

  22. Slide 22: The Bloom Lab analyzes Bloom Test strips in a few minutes

    The Bloom Lab analyzes Bloom Test strips in a few minutes bloom diagnostics

  23. Slide 23: Bloom Diagnostics

    Bloom Diagnostics Zurich Vienna New York www.bloomdiagnostics.com

  24. Slide 24: Outlook and targets

    Alexander Hagemann Outlook and targets

  25. Slide 25: Outlook

    Outlook Expectations for 2020  Assuming there will be no further lockdown in our customer’s markets, Cicor expects a recovery of the business from Q4/2020 onwards  Cicor provides the following guidance for the full year of 2020, assuming a stable currency situation compared to H1/2020:  Net Sales

  26. Slide 26: Mid-term targets

    Mid-term targets Cicor Technologies Ltd. Market Focus Topline growth EBIT target Profit distribution Above the Medical growth of Stable and Industrial global electronics 6 - 8% increasing Aerospace Dividends production 26

  27. Slide 27: Investor Relations

    Investor Relations Contacts Alexander Hagemann Patric Schoch Michael Götti CEO CFO VP Corporate Marketing & Communications Cicor Management AG Gebenloostrasse 15 CH - 9552 Bronschhofen investor@cicor.com +41 71 913 73 00 27

  28. Slide 28: Thank you for your attention

    Thank you for your attention www.cicor.com/investors info@cicor.com

Cicor Technologies — Investora 2020 on 6ix